Effect of DPP-4 inhibitor or Metformin on insulin therapy in patients with type 2 diabetes - Effect of DPP-4 inhibitor or Metformin on insulin therapy in patients with type 2 diabetes

Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine0 个研究点目标入组 40 人开始时间: 2012年6月13日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients with glucagnoma 2) Patients who started in the cure for the past three months 3) Patients who changed in the cure for the past three months 4) Patients with type 1 diabetes.Patients with type 2 diabetes HbA1c>=10.5% or severe ketosis,diabetic coma. 5) Patients treated with oral hypoglycemic agents 6) Patients with nephrosic syndrome 7) Patients treated with steroid, immune-suppressive agent and azole antifungal 8) Patients with allergy against sitagliptin and metformin 9)Patients with exceeding the moderate renal impairment (sCr: male>=1.3mg/dl, female>=1.2mg/dl). 10)Patients with exceeding the moderate liver dysfunction (AST,ALT>3 times upper standard value). 11)Patients who are pregnant, breast-feeding and/or intention to become pregnant 12)Other patients determined to be inappropriate by physician

发起方

Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine